Metronomic capecitabine as second-line treatment for patients with hepatocellular carcinoma with preserved liver function: A phase II study.

被引：1
|
作者：
de Rosa, F.
Agostini, V.
Di Girolamo, S.
Andreone, P.
Trevisani, F.
Bolondi, L.
Pinna, A. D.
Serra, C.
Golfieri, R.
Biasco, G.
Brandi, G.
机构：
[1] Univ Bologna, Bologna, Italy
[2] Azienda Osped Bologna, Policlin S Orsola Malpighi, Bologna, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e14608
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14608
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation
    Trevisani, Franco
    Brandi, Giovanni
    Garuti, Francesca
    Barbera, Maria Aurelia
    Tortora, Raffaella
    Gardini, Andrea Casadei
    Granito, Alessandro
    Tovoli, Francesco
    De Lorenzo, Stefania
    Inghilesi, Andrea Lorenzo
    Foschi, Francesco Giuseppe
    Bernardi, Mauro
    Marra, Fabio
    Sacco, Rodolfo
    Di Costanzo, Giovan Giuseppe
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (02) : 403 - 414
  • [2] Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure
    Granito, Alessandro
    Marinelli, Sara
    Terzi, Eleonora
    Piscaglia, Fabio
    Renzulli, Matteo
    Venerandi, Laura
    Benevento, Francesca
    Bolondi, Luigi
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (06) : 518 - 522
  • [3] Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation
    Franco Trevisani
    Giovanni Brandi
    Francesca Garuti
    Maria Aurelia Barbera
    Raffaella Tortora
    Andrea Casadei Gardini
    Alessandro Granito
    Francesco Tovoli
    Stefania De Lorenzo
    Andrea Lorenzo Inghilesi
    Francesco Giuseppe Foschi
    Mauro Bernardi
    Fabio Marra
    Rodolfo Sacco
    Giovan Giuseppe Di Costanzo
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 403 - 414
  • [4] Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study
    Gardini, Andrea Casadei
    Foca, Flavia
    Scartozzi, Mario
    Silvestris, Nicola
    Tamburini, Emiliano
    Faloppi, Luca
    Brunetti, Oronzo
    Rudnas, Britt
    Pisconti, Salvatore
    Valgiusti, Martina
    Marisi, Giorgia
    Foschi, Francesco Giuseppe
    Ercolani, Giorgio
    Tassinari, Davide
    Cascinu, Stefano
    Frassineti, Giovanni Luca
    SCIENTIFIC REPORTS, 2017, 7
  • [5] Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study
    Andrea Casadei Gardini
    Flavia Foca
    Mario Scartozzi
    Nicola Silvestris
    Emiliano Tamburini
    Luca Faloppi
    Oronzo Brunetti
    Britt Rudnas
    Salvatore Pisconti
    Martina Valgiusti
    Giorgia Marisi
    Francesco Giuseppe Foschi
    Giorgio Ercolani
    Davide Tassinari
    Stefano Cascinu
    Giovanni Luca Frassineti
    Scientific Reports, 7
  • [6] Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study
    Brandi, Giovanni
    de Rosa, Francesco
    Agostini, Valentina
    di Girolamo, Stefania
    Andreone, Pietro
    Bolondi, Luigi
    Serra, Carla
    Sama, Claudia
    Golfieri, Rita
    Gramenzi, Annagiulia
    Cucchetti, Alessandro
    Pinna, Antonio Daniele
    Trevisani, Franco
    Biasco, Guido
    ONCOLOGIST, 2013, 18 (12): : 1256 - 1257
  • [7] Preserving the Liver for Second-Line Treatment of Hepatocellular Carcinoma
    Lencioni, Riccardo
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 6 - 8
  • [8] Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer
    Wu, Zheng
    Gabrielson, Andrew
    Hwang, Jimmy J.
    Pishvaian, Michael J.
    Weiner, Louis M.
    Zhuang, Tingting
    Ley, Lisa
    Marshall, John L.
    He, Aiwu Ruth
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (06) : 1309 - 1314
  • [9] A phase II study of lapatinib and capecitabine in second-line treatment of metastatic pancreatic cancer
    Wu, Zheng
    Marshall, John
    Hwang, Jimmy J.
    Pishvaian, Michael J.
    Wellstein, Anton
    Weiner, Louis M.
    He, Aiwu Ruth
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer
    Zheng Wu
    Andrew Gabrielson
    Jimmy J. Hwang
    Michael J. Pishvaian
    Louis M. Weiner
    Tingting Zhuang
    Lisa Ley
    John L. Marshall
    Aiwu Ruth He
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 1309 - 1314
12345